適應症
藉由放射免疫分析法(RIA)用以定量檢測人體血清或EDTA血漿檢體中1,25二羥維生素D (1,25-Dihydroxyvitamin D)之含量。  
劑型
 
包裝
65100E (100 tests) 
許可證字號
衛部藥製字第018408號 
註銷狀態
註銷日期
2014-04-15  
註銷理由
838 
有效日期
2012-08-06  
發證日期
2007-08-06  
許可證種類
09 
中文品名
“代首林”1, 25二羥維生素D 放射免疫分析試劑 
英文品名
“DiaSorin”1, 25-Dihydroxyvitamin D 
藥品類別
A 臨床化學及臨床毒理學 
申請商地址
台北市大同區承德路二段81號15樓 
通關簽審文件編號
DHAS0601840807 
資料更新時間
 
製造商
名稱 廠址 公司地址 國別 製程
DIASORIN INC. 1951 NORTHWESTERN AVENUE, P. O. BOX 285, STILLWATER, MN 55082-0258, U.S.A. US
成份表
處方標示 成分名稱 含量 單位
1 1.1,25-(OH)2 D NSB Buffer:Potassium phosphate gelatin buffer containing ProClin&reg; 300 (<0.2%).\n2.1,25-(OH)2 D 0 Calibrator:Phosphate buffer containing bovine serum proteins and ProClin 300 (<0.2%).3.1,25-(OH)2 D3 Calibrators (1-5):Lyophilized reagent. Five lyophilized (1,25-(OH)2 D3) calibrators at concentration ranging from 5-200 pg/mL containing human serum and ProClin 300 (<0.2%). Reconstitute each calibrator with 3.0 mL of calibrator zero.4.1,25-(OH)2 D Antiserum:Rabbit anti-1,25-(OH)2 antiserum diluted in phosphate-gelatin buffer containing ProClin 300 (<0.2%).5.125I 1,25-(OH)2 D3:Radio-iodinated 1,25-(OH)2 D3 analogue diluted in an ethylene glycol phosphate buffer.6.1,25-(OH)2 D3 Pretreatment Solution:Potassium phosphate buffer.7.1,25-(OH)2 D Controls:Level 1 (Normal), Level 2 (Elevated):Processed human serum pool, containing ProClin 300 (<0.2%), spiked with appropriate amounts of 1,25-(OH)2 D to obtain control concentrations within the specified ranges. Control 1 is within the normal range.